Study helps to identify medications which are safe to use in treatment of COVID-19

drug
Credit: CC0 Public Domain

A recent study has found that there is no evidence for or against the use of non-steroidal anti-inflammatory drugs such as ibuprofen for patients with COVID-19.

The study, led by researchers at King's College London, also found other types of drugs, such as TNF blockers and JAK inhibitors safe to use.

89 existing studies on other coronavirus strains such as MERS and SARS, as well as the limited literature on COVID-19, were analysed to find out if certain pain medications, steroids, and other drugs used in people already suffering from diseases should be avoided if they catch COVID-19.

Some , for example those with cancer, are already given —therapies that can lower the body's immune system—or immunostimulant drugs—therapies that boost it. If these patients then catch COVID-19, doctors need to know what medication to stop.

Dr. Mieke Van Hemelrijck, a cancer epidemiologist and an author on the paper, said "This pandemic has led to challenging decision-making about the treatment of COVID-19 patients who were already critically unwell. In parallel, doctors across multiple specialties are making clinical decisions about the appropriate continuation of treatments for patients with requiring immune suppressive medication."

The article has been published in ecancermedicalscience, an open access oncology journal, and is authored by researchers from King's College London and Guy's and St. Thomas NHS Foundation Trust, London.

There had been some speculation that non-steroidal anti-inflammatory drugs (NSAIDs) such as ibuprofen might make things worse for some COVID-19 patients, but the researchers did not find evidence to support this statement.

Other types of drugs such as TNF blockers and JAK inhibitors, used to treat arthritis or other forms of inflammation, were also found to be safe to use. Another class of known as anti-interleukin-6 agents is being investigated for helping to fight COVID-19, although there is no conclusive proof yet.

The researchers found that low amounts of prednisolone or tacrolimus therapy may be helpful in treating COVID-19. Co- author, Dr. Sophie Papa, a medical oncologist and immunologist said: "Current evidence suggests that low dose prednisolone (a steroid used to treat allergies) and tacrolimus therapy (an immunosuppressive drug given to patients who have had an ) may have beneficial impact on the course of infections. However further investigation is needed."

As more people catch the disease, researchers will continue to investigate how it interacts with commonly used medications and make further guidance recommendations.


Explore further

Follow the latest news on the coronavirus (COVID-19) outbreak

More information: Beth Russell et al. Associations between immune-suppressive and stimulating drugs and novel COVID-19—a systematic review of current evidence, ecancermedicalscience (2020). DOI: 10.3332/ecancer.2020.1022
Citation: Study helps to identify medications which are safe to use in treatment of COVID-19 (2020, March 30) retrieved 28 October 2020 from https://medicalxpress.com/news/2020-03-medications-safe-treatment-covid-.html
This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.
5 shares

Feedback to editors

User comments